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Congenital heart defects, dysmorphic facial features and intellectual developmental
disorders (CHDFIDD) syndrome in humans was recently associated with mutation
in CDK13 gene. In order to assess the loss of function of Cdk13 during mouse
development, we employed gene trap knock-out (KO) allele in Cdk13 gene. Embryonic
lethality of Cdk13-deficient animals was observed by the embryonic day (E) 16.5, while
live embryos were observed on E15.5. At this stage, improper development of multiple
organs has been documented, partly resembling defects observed in patients with
mutated CDK13. In particular, overall developmental delay, incomplete secondary palate
formation with variability in severity among Cdk13-deficient animals or complete midline
deficiency, kidney failure accompanied by congenital heart defects were detected.
Based on further analyses, the lethality at this stage is a result of heart failure most
likely due to multiple heart defects followed by insufficient blood circulation resulting
in multiple organs dysfunctions. Thus, Cdk13 KO mice might be a very useful model
for further studies focused on delineating signaling circuits and molecular mechanisms
underlying CHDFIDD caused by mutation in CDK13 gene.
Keywords: cyclin-dependent kinase (CDK), cyclin, transcription regulation, development, mouse, cyclin-
dependent kinase 13, cyclin K
INTRODUCTION
Recently, de novo missense variants in Cyclin-dependent kinase 13 (CDK13) gene have been
identified as an emerging factor involved in the onset of congenial heart defects (CHD) in humans
(Sifrim et al., 2016). Documented CHD cases were characterized by ventral and atrial septal defects
accompanied by pulmonary valve abnormalities. CHD patients had syndromic facial gestalt, and
two patients had agenesis of the corpus callosum. Additional mutations within the CDK13 gene
were recognized in humans resembling at clinical level many symptoms previously associated
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with loss of function of CDK13 or newly described symptoms,
such as autism spectrum disorder, seizures, feeding difficulties
and craniofacial dysmorphism including short upslanting
palpebral fissures, hypertelorism or telecanthus, medial epicathic
folds, low-set, posteriorly rotated ears and small mouth with thin
upper lip vermilion (Hamilton et al., 2018). In addition, genome
wide search for de novo mutations responsible for developmental
disorders in patients in Great Britain and Republic of Ireland led
to identification of 14 genes that previously lacked compelling
evidence of involvement in developmental disorders, among
them the CDK13 gene (Deciphering Developmental Disorders
Study, 2017). However, heart defects do not seem to be the
key feature of this disorder since patients with heterozygous
constitutional mutation in CDK13 lacking cardiac anomalies
were reported by two groups (Carneiro et al., 2018; Uehara
et al., 2018). Spectrum of clinical phenotypes of patients with
CDK13 mutations varies from mild to severe with the ubiquitous
intellectual disability and developmental delay (ID/DD) (van
den Akker et al., 2018). Based on these observations, congenital
heart defects, dysmorphic facial features and intellectual
development disorder (CHDFIDD) have been recognized as
novel syndrome caused by de novo variants of CDK13 gene
(Sifrim et al., 2016; Bostwick et al., 2017; Carneiro et al., 2018;
van den Akker et al., 2018).
Human CDK13 protein consists of 1512-amino acids with
a conserved kinase domain surrounded by N- and C-terminal
arms of undefined function (Kohoutek and Blazek, 2012). In
order to be active, CDK13 binds cyclin K (CycK) and forms
enzymatically active complex (Ko et al., 2001; Even et al., 2006;
Bartkowiak et al., 2010; Blazek et al., 2011; Cheng et al., 2012;
Dai et al., 2012; Kohoutek and Blazek, 2012; Liang et al.,
2015). CDK13 belongs to the family of transcription-associated
cyclin-dependent kinases phosphorylating the carboxyl-terminal
domain (CTD) of RNA polymerase II (RNAPII). In particular, the
CDK13 phosphorylates serine 2 (Ser2) and to a lesser extend also
serine 5 (Ser5) within Y1S2P3T4S5P6S7 heptapeptides within the
CTD of RNAPII in vitro (Greifenberg et al., 2016). Nevertheless,
downregulation of CDK13 in tumor derived cell lines had a very
small, if any, effect on level of Ser2 within CTD of RNAPII (Blazek
et al., 2011; Greifenberg et al., 2016). In parallel to CDK13, there
is CDK12 in mammalian cells able to associate with CycK as well
(Blazek et al., 2011; Dai et al., 2012; Liang et al., 2015). Even
though CDK13 shares high amino acid similarity with CDK12,
both kinases appear to function in mutually exclusive complexes
in mammalian cells (Blazek et al., 2011; Kohoutek and Blazek,
2012; Greenleaf, 2018).
In comparison to CDK12, there is a limited number of papers
envisioning the likely function of CDK13 in various biological
processes. For instance, the CDK13 was proposed to be involved
in oncogenesis; yet, its precise function is still under examination
(Kim et al., 2012; Pan et al., 2012). Even though factors involved
in RNA processing, RNA splicing, polyadenylation and RNA
cleavage were demonstrated to bind CDK13 as a result of global
protein-protein interactions, truly associating partners of this
kinase are still unknown (Davidson et al., 2014; Bartkowiak and
Greenleaf, 2015; Liang et al., 2015). In addition to involvement
of CDK13 in diverse cellular processes, this protein participates
in regulation of alternative splicing of HIV-1 or influenza virus
replication, thus suppressing viral production (Berro et al.,
2008; Bakre et al., 2013). In developing mouse embryos and
murine cells, CDK13 regulates hematopoiesis, stemness and
axonal elongation, suggesting an important function in neuronal
development (Pan et al., 2012; Chen et al., 2014).
To this date, the impact of complete loss of Cdk13 function
during mammalian development has not been investigated.
Therefore, we employed a Cdk13 knock-out (KO) mouse model
to explore a novel role of Cdk13 during mouse embryonic
development. We observed embryonic lethality of Cdk13 KO
animals at the embryonic day 16.5. At this stage, improper
development of multiple organs has been observed (heart, brain,
kidney, liver, and palate formation) resembling phenotype of
human patients with de novo missense variants of CDK13
gene. Therefore, our Cdk13-deficient mice may become an
important model to study dysregulation of developmental
processes occurring in human patients.
RESULTS
Disruption of Cdk13 Gene Leads to
Embryonic Lethality in Mice
To examine the role of CDK13 during mouse development, the
mice carrying Cdk13tm1a allele were generated at the Transgenic
and Archiving Module CCP (Institute of Molecular Genetics of
the CAS, Prague). The Cdk13tm1a allele of Cdk13 gene enables
cessation of transcription due to presence of two strong poly A
sites leading to production of the aberrant transcript of Cdk13
mRNA resulting in non-functional truncated form of CDK13
protein harboring only N-terminal part of this protein, without
kinase domain and C-terminal part (Figure 1A). Heterozygous
Cdk13tm1a/+ mice were intercrossed to obtain Cdk13tm1a/tm1a
offspring. Newborn mice were genotyped with specific sets
of primers able to distinguish inserted cassette (257 bp PCR
product, KO) and wild-type (179 bp PCR product, WT) alleles
of Cdk13 gene (Figure 1B). Although the offspring with Cdk13
WT and heterozygous alleles was born at the expected Mendelian
ratio, appeared normal and fertile, Cdk13tm1a/tm1a mice were
not born at all. This finding suggested that a homozygous
deficiency in Cdk13 gene leads to embryonic lethality in mice.
To determine the precise stage, when the embryonic lethality
occurs, mouse embryos were collected at various gestation time
points (Table 1). There were no living Cdk13tm1a/tm1a embryos
after the embryonic stage 15.5 (E15.5) judging by the lack of
their heart beating. Moreover, from E13.5 to E16.5, we observed
increased number of absorbed embryos as a reflection of empty
decidua (Table 1). Based on these finding, we concluded that
the deficiency of Cdk13 causes severe adverse developmental
defects and consequent death from E14.5 resulting in total
lethality before E16.5.
To confirm the loss of CDK13 protein in Cdk13tm1a/tm1a mice,
developing brain from WT and Cdk13tm1a/tm1a homozygous
embryos at E14.5 were collected and western blot analyses were
carried out with specific antibodies recognizing CDK13 protein.
As expected, the WT form of CDK13 was present in Cdk13+/+
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FIGURE 1 | Generation of Cdk13tm1a mice. (A) Scheme of Cdk13tm1a allele. The Cdk13tm1a allele consists of strong splicing acceptor (SA), β-galactosidase gene
(lacZ) and neomycine resistance gene (neo) both with poly A sites (pA), being surrounded by two FRT sites within intron 2, having two and one lox P sites within
intron 2 and 4. (B) PCR genotyping from E12.5 embryos using specific primers distinguishing Cdk13tm1a, mutant (KO, upper bands) and Cdk13+, wild-type, allele
(WT, lower bands). (C) Brain extracts were prepared from E14.5 embryos of Cdk13+/+, Cdk13tm1a/+ and Cdk13tm1a/tm1a mice and protein levels of Ser2 and Ser5
of RNAPII, CDK13 and γ-catenin (CTNNG) were evaluated by Western blotting. The short and long expositions for CDK13 are presented to demonstrate residual
expression of CDK13 in Cdk13tm1a/tm1a embryos.
and Cdk13tm1a/+ mice, but surprisingly, corroborated residual
expression of CDK13 protein was detected in the embryonic
brain of Cdk13tm1a/tm1a homozygous embryos (Figure 1C),
suggesting that Cdk13tm1a/tm1a mice represent a hypomorphic
TABLE 1 | Genotypes of offspring from Cdk13tm1a/+ intercross.
Empty
Stage Cdk13+/+ Cdk13tm1a/+ Cdk13tm1a/tm1a Litters decidua
(25%) (50%) (25%)
E9.5 4 (21.1%) 12 (63.2%) 3 (15.8%)∗ 3 2
E10.5 4 (20%) 10 (50%) 6 (30%)∗ 2 0
E11.5 14 (31.8%) 23 (52.3%) 7 (15.9%)∗ 6 4
E12.5 31 (30.7%) 52 (51.5%) 18 (17.8%)∗,# 15 13
E13.5 6 (16.2%) 18 (48.6%) 13 (35.1%)∗ 5 5
E14.5 48 (27.6%) 95 (54.6%) 31 (17.8%)∗,# 26 9
E15.5 21 (27.5%) 34 (58%) 10 (14.5%)∗ 11 5
E16.5 8 (25%) 18 (56.3%) 6 (18.7%)∗,# 4 0
P0 39 (33.1%) 79 (66.9%) 0 28
∗Growth retardation, #dead embryo.
mutant phenotype. Because the anti-Cdk13 antibody used in
western blot recognizes its N-terminal part of CDK13, we were
curious if the truncated form of CDK13, as a result of terminated
transcription within intron 2, will be expressed in mice bearing
the Cdk13tm1a allele. Indeed, the truncated form of CDK13
was detected in Cdk13tm1a/+ and Cdk13tm1a/tm1a animals
(Supplementary Figure S1). Since CDK13 was demonstrated to
phosphorylate CTD of RNAPII in vitro, we decided to evaluate
phosphorylation status of CTD in hypomorphic mice. Thus,
the effect of CDK13 downregulation on Ser2 was evaluated
in the animal tissue. Even though expression of CDK13 was
significantly lowered in Cdk13tm1a/tm1a mice, no effect on either
Ser2 or Ser5 phosphorylation within CTD of RNAPII was
detected (Figure 1C). The Ser5 phosphorylation was checked in
parallel since it is phosphorylated by other CDK kinase, CDK7 in
particular (Kohoutek, 2009).
Cdk13 Loss Causes Growth Retardation,
Developmental Delay and Its Failure
To examine deficiency of CDK13 protein in Cdk13tm1a/tm1a
mice, morphology at different embryonic stages compared to
the WT animals was examined and various abnormalities were
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FIGURE 2 | Comparison of gross morphology of wild-type, Cdk13tm1a/+ and Cdk13tm1a/tm1a embryos at various stages. Cdk13tm1a/tm1a embryos display
significant growth retardation compared to wild-type and heterozygous embryos. (D–F) Detailed images of Cdk13tm1a/tm1a at relevant developmental stages. (A)
Heterozygous and Cdk13tm1a/tm1a embryos at E12.5. (D) Occasional chest wall deformities manifest at hypomorphs. (B) Wild-type and Cdk13tm1a/tm1a embryos at
E13.5. Cdk13tm1a/tm1a embryo exhibits nuchal edema (black arrow). (E) Hypervascularization of the peripheral vessels capillaries (black arrow). (C) Wild-type and
Cdk13tm1a/tm1a embryos at E14.5. (F, top) Wild-type embryo demonstrates deep indentations between the developing fingers of embryos E14.5, although not yet
separated. (F, bottom) In contrast, Cdk13tm1a/tm1a embryo appears to be 1 day delayed in development as evidenced by the shallow indentation of the footpad,
which is characteristic of embryos E13.5.
observed in Cdk13tm1a/tm1a embryos at each stage of gestation
(Supplementary Figure S2). Observed growth retardation of
Cdk13-deficient mice is presented in detail (Figure 2); however,
the severity of the developmental delay was variable. On average,
the Cdk13tm1a/tm1a embryos appeared to be one embryonic
day behind in comparison to their littermate controls as
evidenced by the shallow indentation of the footpad, which
is characteristic of embryos at E13.5 (Figure 2F, bottom).
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In contrast, Cdk13+/+ littermates exhibited deep indentations
between the developing toes (not yet separated), what is
characteristic of embryos at 14.5 (Figure 2F, top). In addition,
the retarded embryo exhibited nuchal edema (black arrow,
Figure 2B), which correlates with the presence of cardiovascular
phenotypes. Occasionally, the pericardial effusion were detected
in developing Cdk13tm1a/tm1a embryos, most likely caused by
dysfunction of the heart (Figure 2D). Summary of various
developmental defects associated with hypomorphic Cdk13tm1a
allele is presented in Supplementary Table S1.
Cdk13 Is Indispensable for the
Development of Several Organs
To narrow down possible cause of embryonic lethality, embryos
at E14.5 were contrasted with Lugol’s solution to visualize gross
morphology of individual soft tissues by microCT (Figure 3).
Indeed, several developmental abnormalities were detected
within developing embryos. The heart wall of both ventricles
in Cdk13tm1a/tm1a embryos (Figures 3B,D) appeared thinner
in comparison to Cdk13+/+ littermate controls (Figures 3A,C).
In addition, lung, liver and kidney in Cdk13tm1a/tm1a embryos
were smaller and undeveloped (Figures 3D,F,H) in comparison
to Cdk13+/+ littermates (Figures 3C,E,G). However, detailed 3D
reconstruction of liver and kidney (Figures 3I–P) with movable
display of E14.5 embryos of Cdk13tm1a/tm1a and Cdk13+/+
genotypes (Supplementary Figures S3A,B) revealed no defect in
general gross morphology of these organs.
To uncover possible discrepancies in developmental speed
of individual organs, the volume analysis was performed with
normalization to total body volume of given embryo. Liver
size of Cdk13tm1a/tm1a embryos represented only about 46% in
comparison to Cdk13+/+ littermates (Figures 3, 11). Similarly,
kidney size of Cdk13tm1a/tm1a animals comprised only about
52% in comparison to Cdk13+/+. In parallel, histological
sections of selected organs were analyzed at stages between
E14.5 and E16 (Figure 4). Decelerated development of kidneys
was identified in Cdk13tm1a/tm1a embryos at E14.5 and E16
(Figures 4D,F) including nephron differentiation as shown by
altered proportional representation of individual nephron stages
at E14.5 (Figure 4G). Moreover, statistically significant reduction
in the number of S-shaped bodies and glomeruli was observed
in Cdk13tm1a/tm1a embryos (Figure 4H). At lethality stage E16.5,
kidney tissue exhibited tissue abrogation with only few, much
reduced tubules visible (data not shown), very likely caused by
general pre-necrotic changes.
Brains of Cdk13tm1a/tm1a embryos appeared developmentally
delayed as demonstrated by reduced size as compared to
littermate controls. Depicted in Figure 5 are E14.5 controls and
Cdk13tm1a/tm1a mutant samples from two separate litters. The
two litters were developmentally at different stages, pre-palatal
fusion in the control embryo depicted (Figures 5A,B) and post-
palatal fusion in the control embryo depicted (Figures 5E,F).
In order to assess the developmental delay in Cdk13tm1a/tm1a
embryos the cell proliferation was examined by Ki67 staining, a
marker of proliferating cells (Figures 5A’–H’, embryos A and C,
as well as E and G are littermates, representative pictures of two
embryos are shown to display variability in mutant phenotype).
As evident from performed quantification, there was decrease
in number of proliferating cells in Cdk13tm1a/tm1a embryos in
comparison to Cdk13+/+ littermate controls, but this decrease
was not statistically significant (Figure 5I).
The analysis of craniofacial area revealed also defective
palatal shelves development in several Cdk13tm1a/tm1a
embryos resulting in their insufficient horizontal growth
and the formation of the cleft palate at E15.5 (Figure 6) in
Cdk13tm1a/tm1a mouse. Incomplete secondary palate formation
exhibited variability in severity among Cdk13-deficient animals.
Observed penetrance of secondary cleft palate was 2/4 animals at
E15.5. In addition, Cdk13tm1a/tm1a mouse at E15.5 had smaller
number of initiated nasal glands in comparison to the controls
(Supplementary Figure S4, compare A–D and B–E).
Embryonic Lethality in Cdk13tm1a/tm1a
Mice Is Due to Heart Failure
The heart is the one of the first organs to form during mammalian
development. During heart development, significant changes
in organ morphology and cardiomyocyte differentiation and
organization reflect the increasing needs of growing embryos
for nutrition and oxygen supply. Any of these developmental
steps are critical for further development of whole embryos.
Therefore, we analyzed the microscopic structure of the heart
and found that the heart wall of Cdk13tm1a/tm1a mice embryos
was less compact in comparison to the heart wall of Cdk13+/+
mice (Figures 7C,D). Further, apparent disruption of tissue
architecture was detected in Cdk13tm1a/tm1a embryos with the
reduction of myocardium (Figure 7, compare C, E and G to
D, F and H). The heart volume was slightly increased to 103%
(organ ratio to total body volume) in Cdk13tm1a/tm1a mice
compared to Cdk13+/+ animals. However, the total volume
of heart tissue to the organ volume was significantly lower
in case of Cdk13tm1a/tm1a embryos (62.5%) in comparison to
WT littermates (80%) suggestive of the thinner heart wall at
E15.5 in Cdk13tm1a/tm1a embryos. Percent soft tissue volumes
were measured by microCT using Bruker-microCT CT-analyzer,
where the object volume representing soft tissues was divided
by total VOI volume. The VOI area referring to the heart
volume was selected from the dataset manually. Also, decreased
expression of myosin was detected in ventricle myocardium
of 14.5 hearts (Supplementary Figure S5, compare B and
B’ to E and E’).
Since the heart mass of Cdk13tm1a/tm1a E14.5 – E16 embryos
is significantly reduced with hypomorphic muscular layers of
myocardium compared with Cdk13+/+ mice (heart/body ratio),
we presume that heart developmental defect is the cause of
embryonic lethality. In order to evaluate cardiac circulatory
physiology, we performed non-invasive ultrasound Doppler
imaging to quantitatively assess the hemodynamic function in
E14.5 and E15.5 embryos. Out of nine Cdk13tm1a/tm1a embryos
dissected at E14.5 stage, only one was found dead (Table 2).
All the other Cdk13tm1a/tm1a embryos at this stage exhibited
comparable blood flow velocities and velocity-time integral (VTI)
in dorsal aorta (Figures 8A,B). However, this situation changed
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FIGURE 3 | MicroCT analysis of wild-type and Cdk13tm1a/tm1a embryos. High-contrast differentiation resolution by X-ray computed microtomography, where
Lugol’s staining was used to visualize the soft tissues. Sagittal sections through body midline (A,B) and more lateral plane at E15.5 (C,D). Horizontal sections
through lung (E,F) and liver (G,H). 3D reconstruction of kidney and liver in the right side view of embryo (I,J), left side view (K,L) and caudal view (M,N) with embryo
outlined in gray where segmentation of serial sections was used for the liver and kidney reconstruction. (O,P) High power of 3D imaging for liver and kidney.
Horizontal view (Q,R) and sagittal detailed view (S,T) on kidney and suprarenal gland. Abbreviation used for individual organs: ag, adrenal gland; d, diencephalon; h,
heart; hb, hindbrain; k, kidney; l, lung; li, liver; mb, midbrain; t, tongue; te, telencephalon; s, stomach; sc, spinal cord. Scale bar = 1 mm.
dramatically at embryonic stage E15.5 (Figures 8C,D), where
only few Cdk13tm1a/tm1a embryos retained normal blood flow
parameters (5/16), while the rest of the embryos heart functions
declined (standard measurements were not possible due to
irregular or spare heart beating 11/16); moreover, an increased
portion of embryos were already dead (Table 2).
The assessment of cardiac function in developmental
interval E14.5 – E15.5 embryos showed dramatic failure
in heart function, probably corresponding to increasing
needs of embryos at E15.5 for blood supply in growing
organ systems, which is very challenging for the defective
heart to achieve. The preserved blood flow in few
Cdk13tm1a/tm1a embryos was probably due to the observed
variability of the embryo size. Our findings suggest that the
heart failure appears in most cases during the transition
from E14.5 to E15.5.
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FIGURE 4 | Gross anatomy and microscopic structure of kidney in wild-type and Cdk13tm1a/tm1a embryos. (A,B) High power view on segmented kidneys from
Lugol’s stained sections and visualized by X-ray computed microtomography. Growth retardation of kidney is visible in Cdk13tm1a/tm1a embryos at E14.5 (D) and
E16 (F) in contrast to littermate wild-type, Cdk13+/+, controls (C for E14.5 and E for E16). (E,F) Only very few just forming glomeruli (gl) were found in
Cdk13tm1a/tm1a embryos. (G) Relative quantification of individual developmental stages of nephrogenesis in Cdk13+/+ and Cdk13tm1a/tm1a embryos. (H) Increased
amount of renal vesicles together with the reduction of S-shaped bodies and glomeruli (gl) was found in Cdk13tm1a/tm1a embryos. The graph values denote
median ± s.d., ∗p < 0.05, by unpaired t-test. Scale bar (A,B) = 0.3 mm, scale bar (C–H) = 100 µm.
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FIGURE 5 | Cell proliferation in brain area in wild-type and Cdk13tm1a/tm1a embryos. (A,A’,B,B’) Cdk13+/+ and (C,C’,D,D’) Cdk13tm1a/tm1a embryos before palatal
shelves fusion. (E,E’,F,F’) Cdk13+/+ and (G,G’,H,H’) Cdk13tm1a/tm1a embryos after palatal shelves fusion. Immunohistochemical nuclear labeling of Ki67-positive
cells in the frontal head sections in the lower power view (A–H) and in detail (A’–H’). (I) Mitotic index was counted as the ratio between Ki67-positive cells and total
amount of prosencephalon cells in three biological triplicates for each group. The graph values denote mean ± s.d, difference is not statistically significant according
to unpaired t-test (p-value: 0.1047). Ki67-positive cells - brown nuclei, Ki67-negative cells - blue nuclei (hematoxylin). Scale bar (A–C) = 1 mm; scale bar
(A’–C’) = 100 µm.
Cdk13 Is Expressed in Affected Organs
in the Prenatal and Also Postnatal Period
Currently, there is limited information about protein expression
pattern of CDK13 either in developing or adult organs; therefore,
we decided to evaluate expression of CDK13 protein in
developing organs. First, the western blot of CDK13 protein was
carried out in selected developing organs (Figure 9). As expected,
expression of CDK13 was detected in organs with abnormal
embryonic development. The highest protein level of CDK13 was
detected in the brain, then lung, kidney and heart (Figure 9).
In case of detection of CDK13 in the developing heart, four
times concentrated protein lysates had to be used to detect any
reproducible signal.
To explore gene expression of Cdk13 in adult tissues
and organs, the particular organs were isolated and the
expression of Cdk13 was examined by activity of β-galactosidase
(Supplementary Figure S6). Cdk13 was strongly expressed
in the retina of the eye, testes, ovary, uterus, gall bladder
(Supplementary Figures S6A,F–I). To a lesser extent, the
Cdk13 was detected in the urinary bladder (Supplementary
Figure S6D). Interestingly, rather localized, yet strong expression
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FIGURE 6 | Transversal sections of the head in control Cdk13+/+ and Cdk13tm1a/tm1a embryos at E15.5. Rostro-caudal view in Cdk13+/+ animal (A) and four
Cdk13tm1a/tm1a mutant mice to show variability in the secondary palate morphology (B–E). Palatal shelves do not meet each other in the midline (B”’,E”’) and cleft
of secondary palate is visible. Abnormal shape of palatal shelves was observed also caudally with cleft expanding into the soft palate area. (A’–A””, B’–B””, C’–C””,
D’–D””) are transversal sections of head in individual embryos in rostrocaudal direction. Scale bar = 100 µm.
within organ structure was observed in renal pelvis in kidney,
thyroid gland and heart atrium, with substantial expression in the
heart ventricle (Supplementary Figures S6B,C,E).
Cdk13tm1d/tm1d Mice Exhibits More
Severe Phenotype and Earlier Lethality
As we observed residual expression of Cdk13 in analyzed organs
of hypomorphic Cdk13tm1a/tm1a mice, we decided to cross
Cdk13tm1a mice with Flp-deleter mice and Cre-deleter (detailed
description of the utilized transgenic strains is provided at the
Section “Experimental Procedure”) mice to generate Cdk13tm1d
allele with deleted exons 3 and 4 (Figure 10A). As in case
of Cdk13tm1a mice, the expression of CDK13 protein was
investigated in the Cdk13tm1d mice. High expression of CDK13
was detected in the developing brain of WT Cdk13+/+ embryos
(Figure 10B). Greatly downregulated expression of CDK13 was
detected in heterozygous Cdk13tm1d/+ brain with undetectable
expression of CDK13 protein in homozygous Cdk13tm1/tm1d
brain (Figure 10B). As in the case of Cdk13tm1a mice, no
significant reproducible downregulation of Ser2 phosphorylation
was observed in Cdk13tm1d/tm1d brain extract (Figure 10B).
Interestingly, expected Mendelian ratios were reflected in the
portion of Cdk13tm1d/tm1d mice. High number of empty decidua
at E12.5 were detected reflecting increased mortality before this
stage (Table 3). Critically, only 19 litters out of 42 contained
Cdk13tm1d/tm1d embryos suggesting homozygous mice carrying
Cdk13/tm1d alleles exhibited more severe defects in phenotype
than Cdk13tm1a/tm1a mice, especially in craniofacial area with
midline facial cleft (Figure 10C). The prevalence of the midline
orofacial deficiency and pericardial effusion was 60.5% in
Cdk13tm1d homozygous mice at E12.5-E14.5. Out of 94 cases,
only two cases of Cdk13tm1a/tm1a mice had externally visible
orofacial clefting (Supplementary Table S1). The prevalence of
the pericardial effusion (PE) in Cdk13tm1a/tm1a embryos at E12.5-
E14.5 was less than 20% in comparison to high occurrence in
Cdk13tm1d/tm1d embryos (Supplementary Table S1). No PE or
orofacial cleft was recorded in any WT, though 6 embryos from
262 heterozygotes exhibited PE.
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FIGURE 7 | Gross anatomy and microscopic structure of heart in wild-type and Cdk13tm1a/tm1a embryos. (A,B) High power view on segmented heart from Lugol’s
stained sections and visualized by X-ray computed microtomography. (C,D) Sagittal section of heart from Lugol’s staining visualized by X-ray computed
microtomography. Smaller size of heart with broadening of ventricles was visible in Cdk13tm1a/tm1a animals. Abbreviations for the organ structures: ivs,
interventricular septum; mc, myocardium. (E,F) At E14.5, myocardium (mc) of Cdk13tm1a/tm1a mice is already thinner in the ventricle area with small amount of
cardiomyocytes layers, which is in contrast to thick wall of Cdk13+/+ littermate controls. Later, apparent disruption of tissue architecture with enlarged intercellular
spaces and small amount of cardiomyocytes was observed in Cdk13tm1a/tm1a embryos at later stages at E16 (G,H). Scale bar (A,B) = 0.4 mm, scale bar
(C,D) = 350 µm, and scale bar (E–H) = 100 µm.
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TABLE 2 | Summary of ultrasound scanned embryos at E14.5 and E15.5.
Stage Number of embryos Litters Number of Cdk13tm1a/tm1a
Cdk13+/+ Cdk13tm1a/+ Cdk13tm1a/tm1a Heart beating Dying/dead
E14.5 11 27 9 6 8 1
E15.5 14 36 17 8 6 11
Comparison of Cdk13tm1a/tm1a and
Cdk13tm1d/tm1d Mice at E13.5
Finally, the phenotype of Cdk13tm1a/tm1a mice was compared
to Cdk13tm1d/tm1d mice (Figure 11 and Supplementary
Figures S7, S8). High-contrast differentiation resolution
by X-ray computed microtomography was used to assess
gross morphology of the Cdk13+/+, Cdk13tm1a/tm1a and
Cdk13tm1d/tm1d embryos at E13.5. Both Cdk13 mutants
exhibited smaller body size with severe growth retardation
in Cdk13tm1d/tm1d animals (Figures 11A–D). Hypoplasia of
midfacial structures was observed in Cdk13tm1d/tm1d embryos
(Figure 11, compare H to G). The hearts were smaller in
both Cdk13tm1a/tm1a as well as Cdk13tm1d/tm1d embryos in
comparison to littermate control mice with severe ventricle
deficiency detected in Cdk13tm1d/tm1d animals (Figure 11,
compare J to I and L to K). Generally smaller liver were detected
in Cdk13tm1a/tm1a and Cdk13tm1d/tm1d embryos in comparison
to control Cdk13+/+ mice. Liver in Cdk13tm1d/tm1d mice
exhibited abrogated liver lobes arrangement (Figure 11, compare
P to O and N to M). Kidneys in Cdk13tm1d/tm1d mice do not
follow right left kidney asymmetry (Figure 11, compare T to S).
DISCUSSION
Our analysis revealed a new function of Cdk13 in the context of
the mouse development and found that this protein is critical
for proper development at later stages of embryogenesis. Loss
of Cdk13 affects negatively several organs and tissue structures
during mouse development and its inactivation leads to late
embryonic lethality.
Animals with hypomorphic allele (Cdk13tm1a) retained low
residual expression of CDK13 and they were lethal by E16.5
most due to heart failure and delayed development of several
organs was caused likely due to insufficient supply of oxygen
and nutrients. Interestingly, several miRNAs able to target Cdk13
mRNA for degradation were recently recognized during the acute
myocardial infarctions (Wang et al., 2015) supporting the idea
of CDK13 as a strategic molecule for optimal heart function. In
addition, the expression of CDK13 was detectable not just in the
heart, but also in other organs during embryonic development,
such as craniofacial area or brain. However, the expression
only cannot explain the complexity of phenotype exclusively
in tissue autonomous manner or by insufficient nutrients and
oxygen distribution. Thus, we assume that the organs with higher
expression might be affected either by non-functional CDK13
in cell autonomous manner and/or by underdevelopment of
cardiovascular system and lack of nutrients, mostly by insufficient
heart function. Importantly, the affected cardiovascular system
is superior to development of other organ systems and can
drive systemic developmental phenotype; the example of such
phenotype is growth retardation in the whole embryo with no
respect to local CDK13 expression levels, which is affecting size
of all organs within the embryo body. Therefore, in organs where
the expression of CDK13 is under detection limit, we suggest
that the phenotype is caused mostly by failure of cardiovascular
system development and its systemic influence.
It is also interesting why the Cdk13tm1a allele exhibits
the hypomorphic mutant phenotype. One possible explanation
might be due to the insertion of neomycin selection cassette in
non-coding region that has been shown to affect gene expression,
both at the DNA and RNA levels (Pham et al., 1996; Meyers et al.,
1998; Scacheri et al., 2001). Moreover, in silico analyses of post-
transcriptional exon shuffling (PTES) events in humans revealed
high PTES frequencies in CDK13 gene enabling the formation of
aberrant functional CDK13 transcripts (Al-Balool et al., 2011).
In contrast to our observations, genetic depletion of Cdk12, a
kinase with high amino acid similarity to Cdk13, resulted in early
developmental lethality at the blastocyst stage due to deregulated
expression of DNA-damage repair genes leading to enhanced
genomic instability (Juan et al., 2016). Importantly, KO of CycK
resembled the same lethal phenotype at the blastocyst stage as
Cdk12 animals (Blazek et al., 2011). Besides clear effect of CycK
during preimplantation stage, CycK is highly expressed in mouse
embryonic stem cells and testes in a developmentally regulated
manner (Dai et al., 2012). During neonatal spermatogenesis,
CycK is highly expressed in gonocytes, spermatogonial stem
cells and is absent in differentiating spermatogonia, spermatids
and spermatozoa (Xiang et al., 2014). Similar expression in
testes, ovary and uterus was also documented for CDK13 in our
heterozygous mice.
Downregulation of Cdk13 had also significant impact on brain
development. It is known from previous studies that CycK, a
Cdk13 binding partner, has been identified in a genome-wide
screen as one of the factors involved in the formation of the
nervous system in Drosophila (Neumuller et al., 2011). In parallel,
function of CDK12 in process of embryonic neural development
was described in the conditional KO mouse model for this
gene (Chen et al., 2014, 2017). When neuronal differentiation
model of mouse embryonic carcinoma cell (P19) was employed,
CDK12 and CDK13 kinases participated in the axonal elongation
through a common signaling pathway that modulates protein
expression of CDK5 (Chen et al., 2014). Recently, CDK13 was
found remarkably dysregulated in hippocampus and suggested
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FIGURE 8 | Hemodynamic analysis of wild-type, Cdk13tm1a/+ and Cdk13tm1a/tm1a embryos. The non-invasive ultrasound Doppler imaging to quantitatively assess
the heart hemodynamic function in E14.5 and E15.5 embryos was carried out. (A,C) Velocity-time integral in dorsal aorta (DA VTI) and (B,D) Peak Doppler blood
flow velocity measured on E14.5 (A,B) and E15.5 (C,D) day old embryos, respectively.
FIGURE 9 | Expression of CDK13 protein in embryonic mouse organs. Protein extracts were obtained from brain, heart, kidneys and lung of E14.5 Cdk13,
Cdk13tm1a/+ and Cdk13tm1a/tm1a embryos and protein levels of CDK13, Cyclin T1 (CYCT1) and γ-catenin (CTNNG) were evaluated by Western blotting. The
highest expression of CDK13 was observed in brain and kidney, with substantial expression in lung and heart in Cdk13+/+ embryos.
as one of the hub genes useful to elucidate Alzheimer’s disease
(Pang et al., 2017). Importantly, studies of patients with CDK13
mutations suggested their essential role in brain development. As
demonstrated in Figure 5, we were able to observe alteration of
proliferation in neural tissue in Cdk13tm1a mice (as analyzed by
Ki67 expression) however overall changes in brain morphology
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FIGURE 10 | Generation of Cdk13tm1d mice. (A) Scheme of Cdk13tm1d allele harbors deletion of critical exons 3 and 4, causing non-functional allele of Cdk13
gene. (B) Protein extract from the brain was prepared from E14.5 embryos and protein levels of CDK13 and γ-catenin (CTNNG) were evaluated by Western blotting.
No residual expression of CDK13 was observed in Cdk13tm1d/tm1d embryos. Any significant downregulation of Ser2 and Ser5 phosphorylation was not observed in
Cdk13tm1d/tm1d mice. (C) Cdk13tm1d/tm1d embryos exhibited distinct craniofacial phenotype with midfacial hypoplasia in comparison to wild-type embryos. Scale
bar = 0.3 mm.
were not determined. On the other hand, observed proliferation
changes can be also associated with developmental delay of
Cdk13tm1a animals and subventricular zone in brains may
significantly expands later in development. However, it is also
possible that a prominent role of CDK13 may be apparent in
later stages of brain development, for instance, in the axon
pathfinding, synapse formation and etc. Confirmation of this
statement, however, has to be proven in future by employing the
nestin-Cre or CreErt-Flox systems.
Importantly, developmental defects within craniofacial
formation was documented for Cdk13tm1a mice followed by
complete loss of frontonasal part in Cdk13tm1d mice. It is
probably the most surprising observation in respect to patients
with heterozygous mutation of CDK13 gene (Sifrim et al., 2016;
Bostwick et al., 2017; Carneiro et al., 2018; Hamilton et al., 2018).
Moreover, gradual deregulation of CDK13 in mice resulted in
enhanced craniofacial phenotype. The hypomorphic Cdk13tm1a
mice exhibited in the rostral area, altered shape of nasal septa
and later at E15.5, incomplete formation of the secondary
palate was observed in several animals, where palatal shelves
TABLE 3 | Genotypes of offspring from Cdk13tm1d/+ intercross.
Empty
Stage Cdk13 +/+ Cdk13tm1d/+ Cdk13 tm1d/tm1d Litter decidua
(25%) (50%) (25%)
E12.5 33 (27.5%) 69 (57.5%) 18 (15%)∗,# 18 24
E13.5 29 (31.5%) 52 (56.5%) 11 (12%)∗,# 14 5
E14.5 24 (31.2%) 44 (57.1%) 9 (11.7%)∗,# 10 4
∗Growth retardation. #Dead embryos.
did not reach the midline, while control animals exhibited
complete fusion of palatal processes. Nevertheless, complete
depletion of CDK13 in the Cdk13tm1d/tm1d mice led to ablation
of the midline area of the head. There is a limited information
regarding the role of CDK13 in this developmental process at
the moment, yet. The association between SNP polymorphism
rs373711932 located within CDK13 gene and cranial base
width was recently documented (Lee et al., 2017). Importantly,
heterozygous copy number loss of CCNK gene in humans caused
a syndromic neurodevelopmental disorder with distinctive facial
dysmorphism (Fan et al., 2018). Therefore, it seems highly
probable that CDK13 is indeed associated with craniofacial
development, however, with unclear function, which will be
necessary to uncover in the future.
From the functional point of view, it is surprising that only
heterozygous mutation in one allele of the CDK13 gene was
sufficient to cause the CHDFIDD in human patients. Common
feature in all studies depicting deleterious effect of pathogenic
CDK13 in patients was presence of missense substitutions in
the protein kinase domain around ATP-binding and magnesium
binding sites (Sifrim et al., 2016; Bostwick et al., 2017; Hamilton
et al., 2018). In addition, two nonsense variants and a frame-shift
variant accompanying production of aberrant CDK13 transcripts
have been identified (van den Akker et al., 2018). Based on
crystal structure of CDK13/CycK complex, it is very possible that
all these mutations most likely caused inactivation of catalytic
activity of CDK13 or disrupted binding of CycK, its associating
partner, leading to abrogated function of CDK13 (Kohoutek and
Blazek, 2012; Greifenberg et al., 2016; Hamilton et al., 2018).
Nevertheless, some of identified mutations in patients were
predicted to retain binding to cyclin K with affected catalytic
activity. If this is the case, then CDK13/CycK complex represents
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FIGURE 11 | Comparison of Cdk13tm1a and Cdk13tm1d mice at E13.5 High-contrast differentiation resolution by X-ray computed microtomography where Lugol’s
staining was used to visualize the soft tissues. The Cdk13tm1a/tm1a, Cdk13tm1d/tm1d and their littermate controls were analyzed at E13.5. (A–D) Overall view of
Cdk13+/+, Cdk13tm1a/tm1a, and Cdk13tm1d/tm1d embryos. Both mutants exhibited smaller body size, with severe growth retardation in Cdk13tm1d/tm1d animals.
(A’–D’) 3D reconstruction of heart (red color), kidney (violet color) and liver (light pink color) in right side view of embryo, with embryo outlined in gray where
segmentation of serial sections was used for the reconstruction. Liver in Cdk13tm1a/tm1a and Cdk13tm1d/tm1d embryos were smaller than in Cdk13+/+ embryos.
(E–H’) Frontal view of embryos with 3D reconstruction of heart, kidneys and liver. Clear deficiency in development of midfacial structures in Cdk13tm1d/tm1d embryos
in contrast to Cdk13+/+ animals was observed. (I–L) 3D reconstruction of heart. The heart of Cdk13tm1a/tm1a and Cdk13tm1d/tm1d embryos were smaller in
comparison to control mice with severe ventricle deficiency detected in Cdk13tm1d/tm1d animals. (M–P) 3D reconstruction of liver. Generally smaller liver were
observed in Cdk13tm1a/tm1a and Cdk13tm1d/tm1d embryos in comparison to Cdk13+/+ littermate control mice. Liver in Cdk13tm1d/tm1d mice exhibit abrogated liver
parts arrangements. (Q–T) 3D reconstruction of kidneys. Kidneys are smaller with abnormal shape in Cdk13tm1a/tm1a and Cdk13tm1d/tm1d embryos. Scale bar
(A–H) = 1,5 mm, Scale bar (I–L) = 350 µm, scale bar (M,P) = 500 µm, and scale bar (Q–T) = 250 µm.
a dominant negative complex in cells (Hamilton et al., 2018). It is
of note that two patients carrying stop codons at the end of the
kinase domain represented milder phenotypes, although obvious
genotype-phenotype correlation has not been recorded (van den
Akker et al., 2018). From all these results, we can postulate
that even loss of function of one CDK13 allele is enough to
interfere with developmental pathways and cause the CHDFIDD
in humans, while complete abrogation of CDK13 gene would lead
to embryonic lethality as documented in our mouse model.
Currently, we can only speculate how CDK13 contributes to
the developmental processes: if it participates in phosphorylation
of Ser2 within CTD of RNAPII, it is highly probable that
inhibition of CDK13 will block or dramatically affect ability
of RNAPII to effectively synthesize nascent RNA. CDK13
was demonstrated to bind various splicing factors or proteins
involved in splicing (Davidson et al., 2014; Bartkowiak and
Greenleaf, 2015; Liang et al., 2015). Moreover, CDK13 was
found to associate with ASF/SF2 factor, a member of the
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spliceosome complex (Even et al., 2006). CDK13 was also
identified in perinucleolar compartments enriched for proteins
primarily implicated in pre-mRNA processing; therefore, lack of
CDK13 could abrogate also RNA processing of given metazoan
genes (Even et al., 2016). Thus, it is possible that a loss of
kinase activity or associating potential of CDK13 will cripple
proper splicing of transcribed RNA by RNAPII resulting in
production of improperly spliced mRNA of proteins engaged in
development processes.
It has been postulated that CDK13 phosphorylates Ser2 and
Ser5 within CTD of RNAPII, if Ser7 is prephosphorylated
at the C terminus of heptapeptide (Greifenberg et al., 2016).
However, we were not able to detect any effect on Ser2 or
Ser5, either in Cdk13tm1a/tm1a or Cdk13tm1d/tm1d animals with
substantial decreased level of CDK13 in developing brain, where
physiologically high level of CDK13 is present. Even though
the global effect on Ser2 or Ser5 was not documented in
Cdk13tm1a/tm1a developing brains, CDK13 could still orchestrate
phosphorylation of RNAPII at the specific sets of genes as earlier
described for the CDK9/cyclin T2 or CDK12/cyclin K complexes
in mouse and human cells (Zhu et al., 2009; Blazek et al.,
2011; Johnson et al., 2016). When CDK13 was downregulated
in HCT116 cells, gene ontology analysis revealed enrichment of
functions connected to various extracellular and growth signaling
pathways (Liang et al., 2015; Greifenberg et al., 2016). Similar
modus operandi was implicated for CDK9 activation by MEK-1
and MSK1 in response to extracellular cues (Fujita et al., 2008;
Smerdova et al., 2014). In addition, transcriptional kinase CDK8
was described to affect canonical Notch signaling by targeting
activated Notch intracellular domain for proteasomal degradation
(Fryer et al., 2004). In addition, CDK8 was suggested to stabilize
β-catenin interaction with the promoter of WNT targets to
achieve regulatory control (Firestein et al., 2008). Therefore, it is
possible to envision that CDK13 regulates a specific set of genes
at a specific developmental stage of embryonic development
or in specialized cell types. Therefore, it will be critical in
the near future to identify unique genes under control of
CDK13 at given tissue or organ by employment of exome RNA-
sequencing analyses in WT and Cdk13-deficient mice, which will
be our next goal.
We believe that the Cdk13tm1a hypomorphic mouse can be a
very instrumental animal model to delineate cellular pathways
or mechanisms participating in the onset or propagation of
severe developmental cues in humans with mutated form of
CDK13. Moreover, our Cdk13tm1d mouse model with enhanced
craniofacial phenotype may be invaluable for further clarification
of molecular processes, which are responsible for clinical
symptoms of human patients.
EXPERIMENTAL PROCEDURES
Mice, Genotyping, Breeding of
Cdk13tm1a Mice
Mouse embryos (Cdk13tm1a(EUCOM)Hmgu) bearing splicing
acceptor, β-galactosidase and neomycine resistance gene
both with poly A signals (Figure 1A) were obtained from
the Infrafrontier Research Infrastructure–Mouse disease
Models1. The acquired embryos carrying Cdk13tm1a allele were
transferred into pseudopregnant females of C57BL/6N mouse
strain and the heterozygous Cdk13tm1a mice were obtained
at the Transgenic and Archiving Module, CCP (IMG, Prague,
Czechia). Heterozygous mice for Cdk13tm1a allele were bred
and newborn mice were genotyped by PCR amplification (94◦C,
30 s; 62◦C/65◦C, 20 s; 72◦C, 30 s; 35 cycles) of Cdk13 gene to
distinguish WT (Cdk13+/+) and Cdk13tm1a/tm1a alleles. For
PCR analysis, the following sets of primers were used for KO and
WT alleles: (KOf, 5′-CCA GCT TTA AAG GCG CAT AAC-3′;
KOr, 5′-TGA CCT TGG GCA AGA ACA TAA-3′; WTf, 5′-TAG
CTG GCC AAT GAG CTT TC-3′; WTr, 5′-AGT CTA GGA
AGC TGG GAA GAT- 3′). Primers KOf and KOr amplify a
257-bp fragment from Cdk13tm1a allele while primers WTf
and WTr amplify a 179-bp fragment from WT allele. Genomic
DNA was isolated from mouse ears by NaOH extraction (Truett
et al., 2000). Heterozygous mice carrying Cdk13tm1a allele were
bred and after mating, females were examined for vaginal plugs,
embryonic day 0.5 (E0.5) was determined at noon at the day of
vaginal plaque record. Embryos at various stages were obtained
from uteri of pregnant heterozygous female mice, genotyped and
the Mendelian ratios were defined.
To generate mouse carrying the Cdk13tm1d allele, the
Cdk13tm1a/tm1a mice were crossed with the Flp-deleter
mouse strain Gt(ROSA)26Sortm2(CAG−flpo,−EYFP)Ics (MGI:
5285396, Philippe Soriano) and Cre-deleter strain
Gt(ROSA)26Sortm1(ACTB−cre,−EGFP)Ics (MGI: 5285392, Philippe
Soriano) in order to delete critical exons 3 and 4 within Cdk13
gene. All animal procedures were performed in strict accordance
to the Guide for the Care and Use of Laboratory Animals and
approved by the Institutional Animal Care and Use Committee
(Veterinary Research Institute, Brno, Czechia).
Western Blotting
Particular organ from Cdk13tm1a/tm1a, Cdk13tm1a/+ and
Cdk13+/+ embryos at E14.5 were lysed in lysis buffer (100 mM
Tris, pH 7.4; 1% SDS; 10% glycerol) and sonicated. The
brain from Cdk13tm1d/tm1d, Cdk13tm1d/+ and Cdk13+/+ were
lysed in lysis buffer (100 mM Tris, pH 7.4; 1% SDS; 10%
glycerol) and sonicated. Concentrations of total proteins were
determined with bicinchoninic acid (BCA). Lysates were diluted
to the same concentration, mixed with the 3xLaemmli sample
buffer and boiled for 5 min. Western blotting was performed
using anti-mouse CDK13 polyclonal antibody (SAB1302350,
Sigma-Aldrich), γ-catenin (CTNNG) antibody (2309, Cell
Signaling Technology), cyclin T1 (CYCT1) (sc-10750, Santa
Cruz Biotechnology) and anti-serine 2 (Ser2) and serine 5 (Ser5)
rat monoclonal antibodies (clones 3E10 and 3E8 respectively,
ChromoTek GmbH, Germany).
Histological Analysis
Wild-type and homozygous Cdk13tm1a/tm1a embryos at E14.5
to E16.5 were fixed in 4% paraformaldehyde and dehydrated.
After that hearts, brains, kidneys and livers were dissected,
1https://www.infrafrontier.eu/
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embedded in paraffin, and sectioned at 5 µm. Hematoxylin-
eosin (H&E) staining was performed. Images were taken under
bright field using a Leica compound microscope (DMLB2)
with a Leica camera (DFC480) attached (Leica Microsystems,
Wetzlar, Germany).
Immunohistochemistry
Proliferating cells were visualized on E14.5 brain sections by
labeling of Ki67 (positive cells are brown). Sections were
pretreated in Citrate buffer, pH6, 10 mM, 20 min/97◦C in
water bath and were labeled with Ki67 primary antibody
(RBK027-05, Zytomed Systems). For primary antibody detection,
specific secondary antibody and avidin-biotin complex were
used (Vectastain kit, PK-6101, Vector laboratories). The signal
was developed by DAB chromogen system (K3468, DAKO).
Nuclei were counterstained by hematoxylin (blue). Mitotic
index was counted as the ratio between Ki67-positive cells
and total amount of cells in three biological samples for
each group (three Cdk13+/+ embryos, three Cdk13tm1a/tm1a
embryos). Statistical significance in cell number differences
between control and deficient mice were evaluated by unpaired
t-test.
E14.5 heart sections were pretreated in DAKO Target Retrieval
(32367, DAKO) solution for 15 min/97◦C in water bath and
labeled using primary antibodies against actin (sc-1615-R,
Santa Cruz Biotechnology) and myosin (sc-32732, Santa Cruz
Biotechnology). To detect primary antibodies, secondary Alexa
Fluor antibodies (A11004, A11008, Invitrogen) were used. Nuclei
were counterstained by DRAQ5TM (62251, Thermo Scientific).




The embryos at E13.5 or E15.5 were contrasted with Lugol’s
solution to visualize gross morphology of individual soft tissues
by microCT. For the purpose of motion stabilization during
the micro CT scan, mouse embryo was embedded in 1%
agarose gel in Falcon conical centrifuge tube. The micro-CT
scan was performed using - laboratory system GE Phoenix
v| tome| x L 240 (GE Sensing & InspectionTechnologies
GmbH, Germany), equipped with a 180 kV/15W maximum
power nanofocus X-ray tube and high contrast flat panel
detector DXR250 2048 px × 2048 px with 200 µm × 200 µm
pixel size. The measurement was carried out in the air-
conditioned cabinet (21◦C) at acceleration voltage of 60 kV
and X-ray tube current of 200 µA. Thousand nine hundred
projections were taken over 360◦ with exposure time 900 ms
resulting in 5.5 µm voxel resolution. The tomographic
reconstruction was realized by software GE phoenix datos|
x 2.0 (GE Sensing & Inspection Technologies GmbH,
Germany). Reconstructed slice data were processed using
VG Studio MAX 3.1 software (Volume Graphics GmbH,
Germany) and segmentation of liver, kidneys and heart was
completed manually.
Embryonic Ultrasound Imaging and
Doppler Echocardiography
Pregnant females were anesthetized on gestational day 14.5 or
15.5 (before noon) with an isoflurane/oxygen mixture (anesthesia
was initiated with 3–4%, and maintained with 1–2% isoflurane),
and maintained on a temperature-controlled mouse platform
(with sensors for monitoring of maternal electrocardiogram,
respiration and core body temperature). Maternal temperature
was maintained at 34–37◦C, and maternal heart beat at ∼400
beats/minute by adjusting the level of anesthesia. An incision of
about 2–3 cm in the lower abdomen was made, and a uterine horn
was externalized through the incision to provide imaging access.
The number of fetuses in right and left uterine horns was counted
from the mother’s bladder and later during echocardiographic
imaging, labeled as R1, R2, R3, etc (right side) and L1, L2,
L3, etc (left side). Pre-warmed ultrasound gel (37◦C) without
bubbles was applied between the individual fetuses and the
transducer. B-mode imaging scanning of the whole embryo with
the focus on the heart and Color Doppler and PW Doppler
measurements for heart aorta and dorsal aorta were obtained
using a high-frequency ultrasound system (Vevo 2100, FUJIFILM
VisualSonics, Inc., Toronto, ON, Canada) equipped with a MS-
550S transducer operating at a center frequency of 44 MHz.
At the end of imaging of all fetuses, the mother was sacrificed
by cervical dislocation and a small piece of yolk sac of each fetus
was taken for genotyping.
DATA AVAILABILITY
All datasets generated for this study are included in the
manuscript and/or the Supplementary Files.
ETHICS STATEMENT
All animal procedures were performed in strict accordance to the
Guide for the Care and Use of Laboratory Animals and approved
by the Institutional Animal Care and Use Committee (Veterinary
Research Institute, Brno, Czechia).
AUTHOR CONTRIBUTIONS
JKo conceptualized and supervised the project, acquired the
funding, wrote the original draft, and administrated the
project. MN conceptualized the project, contributed to formal
analysis, investigation, and visualization, and wrote, review, and
edited the manuscript. DV contributed to investigation and
visualization. MH contributed to formal analysis, investigation,
and visualization. JP contributed to conceptualization, formal
analysis, supervision, and investigation and wrote, review, and
edited the manuscript. SP and MP contributed to investigation
and visualization. RS supervised the project. MK, TZ, and JKa
contributed to software development and visualization. H-CJ
contributed to investigation, and wrote, review, and edited
the manuscript. M-JF and MB contributed to formal analysis,
supervision, writing, review, and editing.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 16 August 2019 | Volume 7 | Article 155
fcell-07-00155 August 6, 2019 Time: 17:21 # 17
Nováková et al. Function of Cdk13 During Mouse Development
FUNDING
This research was supported by grants n. 16-24043J of
the Czech Science Foundation to JKo, MN, and DV. The
research for this manuscript was financially supported
by the Ministry of Agriculture n. MZE-RO0518, by the
Ministry of Education, Youth and Sports, n. LM2015040 and
LQ1604 by, and by the Ministry of Education, Youth and
Sports and European Fund for Regional Development n.
OP RDE CZ.02.1.01/0.0/0.0/16_013/0001789 and n. OP RDI
CZ.1.05/1.1.00/02.0109 and OP RDI CZ.1.05/2.1.00/19.0395 to
JP, MP, SP, and RS. Work by MB and MH was supported by the
Ministry of Education, Youth and Sports of the Czech Republic
(CZ.02.1.01/0.0/0.0/15_003/0000460). The cooperation between
MB and TZ labs is supported by the Czech Science Foundation
(17-14886S). MicroCT analyses performed by MK, TZ, and JKa
were carried out under the project CEITEC 2020 (LQ1601) with
financial support from the Ministry of Education, Youth and
Sports of the Czech Republic under the National Sustainability
Program II. Work by H-CJ and M-JF was supported by Ministry
of Science and Technology, Taiwan (MOST 106-2811-B-010-046
and MOST 105-2923-B-010 -002 -MY3).
ACKNOWLEDGMENTS
We would like to thank Assoc. Prof. S. Sevcikova for a
critical comments to the manuscript and other members of the
laboratory for helpful inputs.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fcell.2019.00155/
full#supplementary-material
FIGURE S1 | Truncated form of CDK13 protein. (A) Predicted amino acid
sequence of truncated CDK13 protein due to transcriptional block mediated by
two Poly A sites introduced into the intron 2 as part of trap vector in mice bearing
Cdk13tm1a allele. Black and Blue capital letters represent amino acids encoded
within Exon 1 and Exon 2 of Cdk13 gene, respectively. Predicted Molecular weight
of truncated CDK13 protein is 66.22 KDa (https://www.bioinformatics.org/sms/
prot_mw.html). (B) Brain extracts were prepared from E14.5 embryos of given
genotype and protein levels of wild-type and truncated form of CDK13 was
evaluated by Western Blotting. The antibody used throughout our study
recognizes N-terminal part of CDK13, which is expressed in both forms of Cdk13,
wild-type as well as truncated one. The Cdk13+/+ mice contained only the
wild-type CDK13 protein (WT-CDK13). The heterozygous Cdk13tm1a/+ mice
included wild-type (WT-CDK13) and truncated (TR-CDK13) forms of CDK13
protein. The Cdk13tm1a expressed the truncated form of CDK13 and minor
wild-type CDK13 as demonstrated by immunoblot.
FIGURE S2 | Comparison of gross morphology of Cdk13-deficent mice
phenotype. (A–H) Wild-type Cdk13+/+, (I–P) heterozygous Cdk13tm1a/+, and
(Q–X) Cdk13tm1a embryos at various stages. Growth retardation of
Cdk13-deficient mice was apparent from early developmental stages (Q,R). Some
embryos exhibited nuchal edema and peripheral hypervascularization (U) and
abnormal craniofacial shape (S,T). Developmental delay was observed at later
stages (V,W). At E16.5, each of the Cdk13tm1a/tm1a embryos was undergoing
resorption (X). No morphological differences between wild-type and heterozygous
embryos were observed. Scale bar = 0.1 mm.
FIGURE S3 | The 3D reconstruction of selected organs in micro-CT of control
Cdk13+/+ and Cdk13tm1a/tm1a embryos. Overall view on embryos of Cdk13+/+
(A) and Cdk13tm1a/tm1a (B) with 3D reconstruction of heart, liver and kidney (left).
Gross morphology is well visible on movable model on the right side. To visualize
only one organ, click on the lower row and select heart (orange), liver (pink) or
kidney (purple) organ only. Scale bar = 1 mm.
FIGURE S4 | Transversal sections of the head of control Cdk13+/+ and
Cdk13tm1a/tm1a embryos. Transversal sections through the mouse head with
details of the nasal cavity area. At E14.5, no obvious differences were observed
and only one epithelial protrusion (marked by arrow) were developed close to each
nasal cavity (nc) (compare A to D). Later at E15.5, the number of nasal glands was
reproducibly smaller in Cdk13tm1a/tm1a mice in comparison to control animals
(compare B to E). (C,F) Coronal section through the head of embryos at the level
of the eyes. White arrows depict different complexity of the nasal cavity in
wild-type, Cdk13+/+, and Cdk13tm1a/tm1a animals. Abbreviations nc – nasal
cavity, arrowhead – nasal gland. Scale bar (A,B,D,F) = 100 µm and scale bar
(C,F) = 1 mm.
FIGURE S5 | Immunohistochemical detection of myosin and actin in the heart of
Cdk13+/+ and Cdk13tm1a/tm1a embryos. Sagittal sections through the mouse
heart were prepared and immunohistochemical detection of myosin and actin was
carried out with specific antibodies. Decreased expression of myosin was
detected in ventricle myocardium, compare B and B’ to E and E’. Scale bar
(A,D) = 500 µm; Scale bar (B–F, without D) − 100 µm.
FIGURE S6 | The expression of Cdk13 in adult mouse organs visualized by
β-galactosidase activity. The expression of Cdk13 was examined by activity of
β-galactosidase in adult mouse organs (A) eye, (B) heart, (C) thyroid gland,
(D) urinary bladder, (E) kidney, (F) uterus, (G) gall bladder, (H) testes, and
(I) ovary.
FIGURE S7 | Sagittal sections through heads of Cdk13tma1 and Cdk13tm1d and
Cdk13tma1 and Cdk13tm1d mice. High-contrast differentiation resolution by X-ray
computed microtomography where Lugol’s staining was used to visualize the soft
tissues. The Cdk13tm1a/tm1a, Cdk13tm1d/tm1d and their littermate controls are
displayed at E13.5 to show overall developmental delay.
FIGURE S8 | Horizontal sections through heads of Cdk13tma1 and Cdk13tm1d
mice. High-contrast differentiation resolution by X-ray computed microtomography
where Lugol’s staining was used to visualize the soft tissues. The Cdk13tm1a/tm1a,
Cdk13tm1d/tm1d and their littermate controls are displayed at E13.5.
TABLE S1 | The prevalence of developmental defects in Cdk13tma1 and
Cdk13tm1d transgenic mice.
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